How are corticosteroids used to treat minimal change disease in children and adults, including recommended dosing, duration, tapering, and monitoring?

Corticosteroids in Minimal Change Disease

Initial Treatment

For children with new-onset minimal change disease, start prednisone at 60 mg/m²/day (or 2 mg/kg/day, maximum 60 mg/day) as a single daily dose for 4-6 weeks, followed by alternate-day dosing at 40 mg/m² (or 1.5 mg/kg, maximum 40 mg on alternate days) for 2-5 months with gradual tapering, for a total treatment duration of at least 12 weeks. 1

For adults with biopsy-proven minimal change disease, initiate prednisone at 1 mg/kg/day (maximum 80 mg) or alternate-day dosing at 2 mg/kg (maximum 120 mg) for a minimum of 4 weeks if complete remission is achieved, and up to a maximum of 16 weeks if remission is not achieved. 2

Key Differences Between Children and Adults

Children:

• Higher initial dose: 60 mg/m²/day or 2 mg/kg/day (max 60 mg)
• Longer total duration: minimum 12 weeks recommended
• 80% achieve remission within 4-6 weeks 1
• Biopsy not required for initial presentation

Adults:

• Lower initial dose: 1 mg/kg/day (max 80 mg)
• Maximum treatment duration: 16 weeks
• Only 48% achieve remission within 4 weeks; 76% by 8 weeks 3
• Biopsy confirmation mandatory 4

Tapering Strategy

Children

After achieving remission, transition to alternate-day prednisone at 40 mg/m² per dose for 2-5 months with gradual tapering 1. The total treatment course should extend at least 12 weeks, as longer initial therapy (3 months vs 2 months) reduces relapse risk by 30% (RR 0.70; 95% CI 0.58-0.84) 5, 6.

Adults

Begin tapering 2 weeks after achieving complete remission 4. This represents a significant change from older recommendations that required 4 weeks of high-dose therapy even after remission. Taper slowly over a total period of up to 6 months after achieving remission 2. Recent evidence suggests shorter courses (2 months total) may be effective in steroid-sensitive adults, with lower cumulative steroid exposure and no increase in frequent relapses 7.

Treatment of Relapses

Infrequent Relapses

Use the same initial dose and duration as for first presentation 2:

• Children: 60 mg/m²/day until remission for at least 3 days, then 40 mg/m² alternate-day for at least 4 weeks 5
• Adults: 1 mg/kg/day (max 80 mg) for 4 weeks minimum, then taper over 6 months 2

Frequent Relapses or Steroid-Dependent Disease

Do not continue prolonged high-dose corticosteroids. Instead, use steroid-sparing agents 2:

1. Cyclophosphamide (first-line for steroid-sparing): 2-2.5 mg/kg/day for 8 weeks 2, 6

   • Curative potential with 66% remaining in remission at 5 years in adults 8
   • Should be used before calcineurin inhibitors 6
   • Avoid in children with steroid-resistant disease 2

2. Calcineurin Inhibitors (for those who relapse after cyclophosphamide or wish to preserve fertility):

   • Cyclosporine: 3-5 mg/kg/day in divided doses, target trough 60-150 ng/mL 2, 9
   • Tacrolimus: 0.05-0.1 mg/kg/day in divided doses, target trough 5-10 ng/mL 2, 9
   • Continue for 1-2 years (children) or at least 12 months 2, 9

3. Rituximab (for frequently relapsing/steroid-dependent disease in adults) 4, 9

4. Mycophenolate mofetil: 500-1000 mg twice daily for patients intolerant of corticosteroids, cyclophosphamide, and CNIs 2

Monitoring During Treatment

Check the following at 3-6 month intervals:

• Serum AST/ALT
• Total bilirubin
• Gamma-globulin or IgG levels 10
• Complete blood count (when using immunosuppressants) 9
• CNI trough levels (if applicable) 9

For children on alternate-day prednisone: Consider daily dosing during upper respiratory infections to reduce relapse risk 5.

Special Situations

Contraindications to High-Dose Corticosteroids

For patients with uncontrolled diabetes, psychiatric conditions, or severe osteoporosis, use oral cyclophosphamide or calcineurin inhibitors as initial therapy 2.

Acute Kidney Injury with MCD

Treat with corticosteroids as for first episode of MCD, along with renal replacement therapy if indicated 2. AKI occurs in up to 25% of adult MCD cases and is typically reversible with steroid treatment 1.

Dosing in Overweight Children

Base dosing on ideal body weight rather than actual weight to avoid unnecessary steroid exposure 1. Consider maximum daily dose of 80 mg prednisone 1.

Critical Pitfalls to Avoid

1. Do not stop corticosteroids abruptly after short courses - taper over 6 months in adults, 2-5 months in children after remission
2. Do not extend high-dose therapy beyond 16 weeks in adults - increases toxicity without improving remission rates 4, 1
3. Do not use cyclophosphamide in children with steroid-resistant nephrotic syndrome - it is ineffective in this population 2
4. Do not use statins or ACE inhibitors/ARBs routinely for initial MCD episodes - they are unnecessary if rapid remission occurs 2, 1
5. Do not assume all adult nephrotic syndrome is MCD - biopsy confirmation is mandatory as MCD represents only 10-15% of adult cases 1